​

Omega Therapeutics Ownership | Who Owns Omega Therapeutics?

OverviewForecastRevenueFinancialsChart

Omega Therapeutics Ownership Summary

Omega Therapeutics is owned by 3.27% institutional investors, 1.67% insiders, and 95.06% retail investors. Wells fargo & company/mn is the largest institutional shareholder, holding 0.03% of OMGA shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.09% of its assets in Omega Therapeutics shares.

OMGA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOmega Therapeutics3.27%1.67%95.06%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Wells fargo & company/mn18.44K0.03%$13.75K
Renaissance17.82K0.03%$13.29K
Barclays13.28K0.02%$10.00K
Steward partners investment advisory5.00K0.01%$3.73K
Principal securities1.37K0.00%$1.02K
Group one trading900.000.00%$671.00K
Tower research capital llc (trc)---
Harbourvest partners---
Geode capital management---
Hm payson---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
683 capital management---
Geode capital management---
Renaissance17.82K-$13.29K
Point72 asset management---
Harbourvest partners---
Tower research capital llc (trc)---
Two sigma securities---
Barclays13.28K-$10.00K
Hm payson---
Woodline partners lp---

Top Buyers

HolderShares% AssetsChange
Principal securities1.37K--
Steward partners investment advisory5.00K--
Huntington national bank1.00--
Barclays13.28K--
Srs capital advisors---54.00

Top Sellers

HolderShares% AssetsChange
Flagship pioneering---29.23M
Fmr---5.92M
Harbourvest partners---3.51M
State of wisconsin investment board---1.86M
Siren---1.32M

Sold Out

HolderChange
Srs capital advisors-54.00
Advisor group-200.00
Bnp paribas arbitrage, snc-235.00
Harbour investments-275.00
Tower research capital llc (trc)-292.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202413-76.36%1,801,047-96.27%30.04%4-73.33%3-76.92%
Sep 30, 202455-20.29%48,291,711-4.44%871.04%15-50.00%13-38.10%
Jun 30, 202469-5.48%50,536,106-1.17%911.07%30-18.92%2150.00%
Mar 31, 20247312.31%51,136,5801.80%921.12%3723.33%14-30.00%
Dec 31, 2023656.56%50,233,395-1.29%911.07%3011.11%2042.86%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S2.82M5.09%-
Fidelity Growth Company Fund1.96M3.55%-4.04K
Vanguard Total Stock Mkt Idx Inv779.10K1.41%-
Fidelity Growth Company K6741.11K1.34%-7.38K
Fidelity Series Growth Company389.58K0.70%-30.70K
Vanguard Institutional Extnd Mkt Idx Tr309.87K0.56%-
Galileo - Biotech Innovation Fund S USD175.00K0.32%-
Fidelity Extended Market Index119.92K0.22%-1.82K
Bridgeway Ultra-Small Company Market64.00K0.12%-55.00K
iShares Micro-Cap ETF59.57K0.11%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 02, 2023Young Richard A-Sell$40.00K
May 01, 2023Young Richard A-Sell$40.00K
Apr 06, 2023Young Richard A-Sell$40.00K
Mar 17, 2023Young Richard A-Sell$80.00K
Feb 27, 2023Flagship Pioneering Inc.-Buy$11.53M

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q3--
2023 Q2-3

OMGA Ownership FAQ

Who Owns Omega Therapeutics?

Omega Therapeutics shareholders are primarily institutional investors at 3.27%, followed by 1.67% insiders and 95.06% retail investors. The average institutional ownership in Omega Therapeutics's industry, Biotech Stocks , is 63.96%, which Omega Therapeutics falls below.

Who owns the most shares of Omega Therapeutics?

Omega Therapeutics’s largest shareholders are Wells fargo & company/mn (18.44K shares, 0.03%), Renaissance (17.82K shares, 0.03%), and Barclays (13.28K shares, 0.02%). Together, they hold 0.09% of Omega Therapeutics’s total shares outstanding.

Does Blackrock own Omega Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Omega Therapeutics.

Who is Omega Therapeutics’s biggest shareholder by percentage of total assets invested?

683 capital management is Omega Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Omega Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Omega Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Omega Therapeutics shares, with 5.09% of its total shares outstanding invested in 2.82M Omega Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools